Hamilton Lane Inc

Hamilton Lane Inc(HLNE)股票分析

$81.840

-1.629 (-1.99%)收盘时

Loading chart…
最高
85.415
开盘
84.200
成交量加权均价
82.49
成交量
766.26K
市值
4.92B
最低
80.205
成交额
63.21M
企业价值/息税折旧摊销前利润(TTM)
11.51

Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.

AI 分析 of Hamilton Lane Inc (HLNE)

持有

Hamilton Lane Inc (HLNE) is currently trading at $81.84, which is significantly below the average analyst price target of $116.67, indicating potential for upside. However, the RSI is at 30.54, suggesting the stock is oversold, but it has also experienced a 40.11% decline year-to-date, indicating significant downward pressure. The forward P/E ratio is 12.02, which is relatively low, suggesting the stock could be undervalued. The main risk is the recent performance trend, with a 5-day change of -4.47% and a 20-day change of -6.72%, which may deter new investors in the short term.

分析师评级(5)

上行空间 +123.20%
持有
1 买入
4 持有
0 卖出
当前: 81.84
最低
159.00
平均
182.67
最高
230.00

Goldman Sachs

2026-10-02

目标价

$117

买入

Wells Fargo

2026-10-01

目标价

$103

增持

UBS

2026-08-05

目标价

$131

买入

Oppenheimer

2026-08-05

目标价

$182

跑赢大盘

Morgan Stanley

2026-07-21

目标价

$123

Equal Weight

估值指标

Hamilton Lane Inc(HLNE)当前预期市盈率为 12.02,5 年平均预期市盈率为 25.18。

预期市盈率

低估
5 年均值 P/E
25.18
当前P/E
12.02
高估
31.95
低估
18.40

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
15.81
当前EV/EBITDA
11.51
高估
19.36
低估
12.26

预期市销率

合理
5 年均值 P/S
7.16
当前P/S
5.37
高估
8.97
低估
5.34

Alphio AI 对 HLNE 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HLNE

$250.34

情景价格

基

基准

基准 · 50%HLNE

$232.24

情景价格

悲

悲观

悲观 · 25%HLNE

$204.90

情景价格

持有 HLNE 的大户

D

D.F. Dent and Company, Inc.

+ 持有HLNE

+1.56%

3个月收益率

C

Copeland Capital Management, LLC

+ 持有HLNE

-7.87%

3个月收益率

事件时间线

2026-10-15 (ET)

07:30:00

Hamilton Lane Appoints Hartley Rogers as Co-CEO

2026-09-15 (ET)

10:00:00

Columbia Threadneedle and Hamilton Lane Announce Strategic Collaboration

2026-07-01 (ET)

20:30:00

Hamilton Lane Prepares First Yuan-Denominated Fund

2026-06-23 (ET)

09:30:00

Gridline Announces Strategic Partnership with Hamilton Lane

资讯

HLNE 常见问题 —— 由 Alphio AI 解答

Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics. It operates in the Financials sector (INVESTMENT ADVICE industry).

Hamilton Lane Inc (HLNE) is currently trading at $81.84, which is significantly below the average analyst price target of $116.67, indicating potential for upside. However, the RSI is at 30.54, suggesting the stock is oversold, but it has also experienced a 40.11% decline year-to-date, indicating significant downward pressure. The forward P/E ratio is 12.02, which is relatively low, suggesting the stock could be undervalued. The main risk is the recent performance trend, with a 5-day change of -4.47% and a 20-day change of -6.72%, which may deter new investors in the short term.

5 analysts cover HLNE: 1 rate it Buy, 4 Hold and 0 Sell. The average price target is 182.67.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易